2020 / 02

DOI: 10.24075/brsmu.2020.014

ORIGINAL RESEARCH

Preventive pharmacotherapy of type 2 diabetes mellitus in patients with early carbohydrate metabolism disorders: long-term efficacy and clinical outcomes

Boeva VV1, Zavyalov AN2
About authors

1 Department of Endocrinology, Federal Clinical Centre of High Medical Technologies, Moscow Region, Novogorsk, Russia

2 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Valentina V. Boeva
Ivanovskaya, 15A, Khimki, Moscow region, 141435; ur.xednay@VVaveob

About paper

Author contribution: Boeva VV planned the study; analyzed the literature; collected, analyzed and interpreted study results; wrote the manuscript; Zavyalov AN analyzed the literature; analyzed and interpreted study results; wrote the manuscript.

Received: 2020-01-09 Accepted: 2020-02-08 Published online: 2020-03-06
|
  1. State Diabetes Register. Professional All-Russian Resource on Diabetes Nosology under the auspices of Endocrinology Research Center. Available from: http://diaregistry.ru/content/o-proekte.html#content. Verified on May 28, 2018. Russian.
  2. Dedov II, Shestakova MV, editors. Algorithms of Specialized Medical Care for Diabetes Mellitus Patients. 9th ed. Moscow, 2019. Russian.
  3. Dedov II, Shestakova MV, Galstyan GR. Prevalence of Type 2 Diabetes Mellitus in Adult Russian Population (NATION study). Diabetes Mellitus. 2016; 19 (2): 104–12. Russian.
  4. Ametov AS. Saharnyj diabet 2-go tipa. Problemy i reshenija. M.: GEOTAR-Media, 2017; s. 125–144. Russian.
  5. Barry E. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ. 2017 Jan 4; (356): i6538.
  6. Аmetov АS, Кrivosheyeva АА. Prevention of type 2 diabetes mellitus. Endocrinology. 2017; (4): 14–25.
  7. Chazova IE, Mychka VB, Belenkov YuN. Osnovnye rezul'taty Rossijskoj programmy ''APREL'' (jeffektivnost' primenenija akarbozy u pacientov s narushennoj tolerantnost'ju k gljukoze i arterial'noj gipertoniej). Consilium medicum. 2005; (2): 18–22. Russian.
  8. Madsen KS, Chi Y, Metzendorf MI, Richter B, Hemmingsen B. Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2019; (12): CD008558
  9. Demidova IYu, Boeva VV. Early diagnosis and treatment of the initial stages of carbohydrate metabolism disorders. Bulletin of The Russian State Medical University. 2013; (1): 9–13.
  10. Diabetes Care. 2019; 42 (Suppl. 1): 29–33.
  11. Аmetov АS, Кrivosheyeva АА. Prospects of early pharmacological intervention at the stage of prediabetes. Endocrinology. 2018; 7 (3): 75–87.
  12. Naidoo P, et al. Effect of Sitagliptin and Metformin on prediabetes progression to type 2 diabetes — a randomized, double-blind, double-arm, multicenter clinical trial: protocol for the sitagliptin and metformin in prediabetes (SiMePreD) study. JMIR Res Protoc. 2016; 5 (3): e145.
  13. International Diabetes Federation. Clinical Practice Recommendations for managing Type 2 Diabetes in Primary Care, 2017.
  14. Gosudarstvennyj reestr lekarstvennyh sredstv. Instrukcija po primeneniju lekarstvennogo preparata dlja medicinskogo primenenija gljukofazh, izmenenie # 4 k P N014600/01-140812 ot 6.07.2016 g. S. 3. Data pereoformlenija: 04.04.2018 g. Russian.
  15. Gosudarstvennyj reestr lekarstvennyh sredstv. Instrukcija po medicinskomu primeneniju preparata gljukobaj. Registracionnyj nomer P N012033/01 ot 24.06.2005 g. S. 2. Data pereoformlenija: 24.08.2017 g. Russian.
  16. Dedov II, Shestakova MV, redaktory. The results of the implementation of the “Diabetes mellitus” subprogram of the Federal target program “Prevention and Control of Socially Significant Diseases 2007–2012”. Diabetes; 2013; (2): 2–48.
  17. Prikaz Minzdrava Rossii ot 3 dekabrja 2012 g. # 1006n. Available from: https://normativ.kontur.ru/document?moduleId=1&docume ntId=212999. Russian.
  18. Dolgov VV, Selivanova AV, i dr. Laboratornaja diagnostika narushenij obmena uglevodov. Metabolicheskij sindrom. Saharnyj diabet. M.-Tver': Triada, 2006; 128 s. Russian.
  19. Chiasson J-L, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002 Jun 15; 359 (9323): 2072–7.
  20. Wenying Y, Lixiang L, Jinwu Q. The preventive effect of acarbose and metformin on the progression to diabetes mellitus in the IGT population: 3-year multicenter prospective study. Chin J Endocrin Metab. 2001; (17): 131–6.